Keiji Itaka

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Topics

Human Serum Albumin

Cerebrospinal Fluid

Magnetic Resonance Imaging

Top Venues

Nanomaterials (Basel, Switzerland)

Inflammation and regeneration

This page only lists publications with an associated author ORCID identifier.

Publications

Takayuki Koga, Hiroshi Kida, Yutaro Yamasaki, Loreto B Feril, Hitomi Endo, Keiji Itaka, Hiroshi Abe, Katsuro Tachibana
Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound. Nanomaterials (Basel, Switzerland) 14 (3) (2024)
Takayuki Koga, Hiroshi Kida, Yutaro Yamasaki, Loreto B Feril, Hitomi Endo, Keiji Itaka, Hiroshi Abe, Katsuro Tachibana
Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound. Nanomaterials (Basel, Switzerland) 14 (3) (2024)
Takayuki Koga, Hiroshi Kida, Yutaro Yamasaki, Loreto B Feril, Hitomi Endo, Keiji Itaka, Hiroshi Abe, Katsuro Tachibana
Intracranial Gene Delivery Mediated by Albumin-Based Nanobubbles and Low-Frequency Ultrasound. Nanomaterials (Basel, Switzerland) 14 (3) (2024)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Xuan Du, Erica Yada, Yuki Terai, Takuya Takahashi, Hideyuki Nakanishi, Hiroki Tanaka, Hidetaka Akita, Keiji Itaka
Comprehensive Evaluation of Lipid Nanoparticles and Polyplex Nanomicelles for Muscle-Targeted mRNA Delivery. Pharmaceutics 15 (9) (2023)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Hsi-Kai Tsou, Cheng-Hsin Wu, Long Yi Chan, Kazunori Kataoka, Nanae Itokazu, Minoru Tsuzuki, Hsuan Hu, Guan-Yu Zhuo, Keiji Itaka, Chin-Yu Lin
Administration of mRNA-Nanomedicine-Augmented Calvarial Defect Healing via Endochondral Ossification. Pharmaceutics 15 (7) (2023)
Maorui Zhang, Yuta Fukushima, Kosuke Nozaki, Hideyuki Nakanishi, Jia Deng, Noriyuki Wakabayashi, Keiji Itaka
Enhancement of bone regeneration by coadministration of angiogenic and osteogenic factors using messenger RNA. Inflammation and regeneration 43 (1) (2023)
Kendall Free, Hideyuki Nakanishi, Keiji Itaka
Development of Synthetic mRNAs Encoding Split Cytotoxic Proteins for Selective Cell Elimination Based on Specific Protein Detection. Pharmaceutics 15 (1) (2023)
Hiroshi Kida, Yutaro Yamasaki, Loreto B Feril, Hitomi Endo, Keiji Itaka, Katsuro Tachibana
Efficient mRNA Delivery with Lyophilized Human Serum Albumin-Based Nanobubbles. Nanomaterials (Basel, Switzerland) 13 (7) (2023)
Jia Deng, Yuta Fukushima, Kosuke Nozaki, Hideyuki Nakanishi, Erica Yada, Yuki Terai, Kenji Fueki, Keiji Itaka
Anti-Inflammatory Therapy for Temporomandibular Joint Osteoarthritis Using mRNA Medicine Encoding Interleukin-1 Receptor Antagonist. Pharmaceutics 14 (9) (2022)